| Section | Status | CDF | Name |
| 08.01.05 | Formulary |  |
Alectinib Alecensa® |
| 08.01.05 | Formulary | |
Avelumab Bavencio® |
| 08.01.05 | Formulary | |
Bendamustine |
| 08.01.05 | Formulary | |
Bevacizumab Avastin® |
| 08.01.05 | Formulary | |
Bortezomib Velcade® |
| 08.01 | Formulary | |
Bosutinib Bosulif® |
| 08.01.05 | Formulary | |
Brentuximab Adcetris® |
| 08.01.05 | Formulary | |
Cabazitaxel Jevtana® |
| 08.01.05 | Formulary | |
Cabozantinib Cabometyx® |
| 08.01.05 | Formulary | |
Cabozantinib Cometriq® |
| 08.01.05 | Formulary | |
Ceritinib Zykadia® |
| 08.01.05 | Formulary | |
Cetuximab Erbitux® |
| 08.01.03 | Formulary | |
Clofarabine |
| 08.01.05 | Formulary | |
Crizotinib Xalkro® |
| 08.01.05 | Formulary | |
Dabrafenib Tafinlar® |
| 08.01.05 | Formulary | |
Dasatinib Sprycel® |
| 08.01.02 | Formulary | |
Doxorubicin Pegylated Liposomal Infusion Caelyx® |
| 08.03.03 | Formulary | |
Enzalutamide Xtandi® |
| 08.01.05 | Formulary | |
Eribulin Halaven® |
| 08.01.05 | Formulary | |
Ibrutinib Imbruvica® |
| 08.02.04 | Formulary | |
Lenalidomide Revlimid® |
| 08.01.05 | Formulary | |
Lenvatinib Lenvima® |
| 08.01.03 | Formulary | |
Nelarabine |
| 08.01.05 | Formulary | |
Nivolumab Opdivo® |
| 08.01.05 | Formulary | |
Olaparib Lynparza® |
| 08.01.05 | Formulary | |
Osimertinib Tagresso ® |
| 08.01.05 | Formulary | |
Panitumumab Vectibix® |
| 08.01.03 | Formulary | |
Pemetrexed Alimta® |
| 08.01.05 | Formulary | |
Pertuzumab Perjeta® |
| 08.03.04.02 | Formulary | |
Radium-223 dichloride Xofigo® |
| 08.01.05 | Formulary | |
Regorafenib Stivarga® |
| 08.01.05 | Formulary | |
Sorafenib Nexavar® |
| 08.01.05 | Formulary | |
Sunitinib Sutent® |
| 08.01.05 | Formulary | |
Temsirolimus Torisel® |
| 08.01.05 | Formulary | |
Tivozanib Fotivda® |
| 08.01.05 | Formulary | |
Trametinib Mekinist® |
| 08.01.05 | Formulary | |
Trastuzumab Herceptin® |
| 08.01.05 | Formulary | |
Venetoclax Venclyxto® |